ESC 365 - Stroke, mortality, and major bleeding among patients with atrial fibrillation and chronic kidney disease; insights from a contemporary large-scale population study

ESC Professional Premium Access

Stroke, mortality, and major bleeding among patients with atrial fibrillation and chronic kidney disease; insights from a contemporary large-scale population study

Session: Atrial fibrillation and stroke: role of kidney disease and biomarkers

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor Y. Ben Baruch Golan (Beer Sheva, IL)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Yael Ben Baruch Golan

Soroka University Medical Center, Beer Sheva (Israel)

1 presentation

1 follower

3 more presentations in this session

Kidney function by creatinine and cystatin c and adverse cardiovascular outcomes in patients with atrial fibrillation

Speaker: Mr A. Schweigler (Basel, CH)

The relationship between changes of antithrombotic drug regimen after ischemic stroke and risks of clinical outcomes in patients with atrial fibrillation

Speaker: Doctor T. Chao (Taipei, TW)

Neurofilament light chain (NFL) - a neuron-specific plasma biomarker for evaluating risk of ischemic cerebral events in atrial fibrillation

Speaker: Doctor J. Aulin (Uppsala, SE)

Access the full session

Atrial fibrillation and stroke: role of kidney disease and biomarkers

Speakers: Doctor Y. Ben Baruch Golan, Mr A. Schweigler, Doctor T. Chao, Doctor J. Aulin

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources